Get the Stockscreener App
815.20
1.20%
-7.43
After Hours:
815.20
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $815.20, with a volume of 1.29M.
It is down -1.20% in the last 24 hours and down -5.51% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$822.63
Open:
$818.22
24h Volume:
1.29M
Relative Volume:
1.62
Market Cap:
$99.85B
Revenue:
$397.96B
Net Income/Loss:
$4.55B
P/E Ratio:
23.45
EPS:
34.7654
Net Cash Flow:
$9.64B
1W Performance:
-2.79%
1M Performance:
-5.51%
6M Performance:
-1.54%
1Y Performance:
+14.03%
1-Day Range:
$791.09
$822.21
1-Week Range:
$791.09
$841.85
52-Week Range:
$637.00
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
815.20 | 102.28B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
308.01 | 60.69B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
192.88 | 48.38B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.59 | 8.73B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.19 | 2.00B | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
Vanguard Capital Management (NYSE: MCK) reports 9.18M shares, 7.49% - Stock Titan
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo! Finance Canada
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
BLACKROCK CAPITAL APPRECIATION FUND, INC.'s McKesson Corp(MCK) Holding History - GuruFocus
GLP-1 trade? McKesson is your stock, this investor says - Cantech Letter
naturemary Secures National Distribution with McKesson Canada, Unlocking Access to Thousands of Pharmacies - The National Law Review
McKesson Corp enters new revolving credit facility on April 24, 2026 - marketscreener.com
McKesson Corporation (MCK) Enters New $5 Billion Revolving Credi - GuruFocus
MCK Initiates Coverage On McKesson by William Blair -- Rating: O - GuruFocus
McKesson Secures New $5 Billion Revolving Credit Facility - TipRanks
McKesson (NYSE: MCK) secures $5B credit line maturing in 2031 - Stock Titan
SIMT GLOBAL MANAGED VOLATILITY FUND's McKesson Corp(MCK) Holding History - GuruFocus
McKesson announces changes to organizational structure - MSN
McKesson Corporation stock (US58155Q1031): Why Google Discover changes matter more now for healthcar - AD HOC NEWS
Impax Asset Management Group plc Takes $1.10 Million Position in McKesson Corporation $MCK - MarketBeat
McKesson Corporation stock (US58155Q1031): Why Google Discover changes matter more now - AD HOC NEWS
Axecap Investments LLC Has $2.34 Million Holdings in McKesson Corporation $MCK - MarketBeat
McKesson raises FY26 EPS outlook following quarterly beats - MSN
Calamos Advisors LLC Sells 1,237 Shares of McKesson Corporation $MCK - MarketBeat
McKesson Corporation (MCK) is a trending stock: Facts to know before betting on it - MSN
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
McKesson Corporation $MCK Shares Sold by Arizona State Retirement System - MarketBeat
McKesson to Buy Majority of Core Ventures for $2.5B - Modern Distribution Management
MCK Fundamental Analysis & Valuation | Fair Value & Financial Strength | MCKESSON CORP (NYSE:MCK) - ChartMill
Gordon Reid's Top Picks: GATX Corp., General Motors & McKesson - BNN Bloomberg
Healthcare Briefs: McKesson Signs $1.25 Billion Deal With Apollo Funds for Minority Stake in MSS Business - D Magazine
Assessing McKesson (MCK) Valuation As Dividend And Earnings Growth Expectations Draw Focus - Yahoo Finance
Investors heavily search McKesson Corporation (MCK): Here is what you need to know - MSN
McKesson Corporation $MCK Holdings Raised by B. Metzler seel. Sohn & Co. AG - MarketBeat
McKesson Corporation Plans Quarterly Dividend of $0.82 (NYSE:MCK) - MarketBeat
Apollo’s McKesson Takeover Bet Signals A Bigger Strategy Unfolding! - Smartkarma
McKesson Corporation (MCK) Stock: Is It Gaining Traction (Wavering) 2026-04-22Top Analyst Picks - Xã Thanh Hà
McKesson Keeps Quarterly Dividend at $0.82 a Share, Payable July 1 to Shareholders of Record on June 1 - marketscreener.com
What McKesson (MCK)'s Dividend Declaration and Q4 Earnings Prep Means For Shareholders - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $93.13 Million Stock Position in McKesson Corporation $MCK - MarketBeat
McKesson declares 82 cent quarterly dividend - Investing.com
McKesson declares 82 cent quarterly dividend By Investing.com - Investing.com Canada
McKesson Corporation Declares Quarterly Dividend - The Joplin Globe
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B - Fierce Biotech
McKesson Corporation $MCK Position Increased by M&T Bank Corp - MarketBeat
Assessing McKesson (MCK) Valuation After Robust Results And Strong Buybacks Attract Investor Interest - simplywall.st
BofA lowers McKesson (MCK) price target, flags GLP-1 pricing pressure - MSN
McKesson To Sell $1.25B Minority Stake in Medical-Surgical Unit to Apollo Ahead of Planned IPO - Dallas Innovates
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Is McKesson Stock Still A High-Conviction Compounder? - Forbes
TD Waterhouse Canada Inc. Sells 3,582 Shares of McKesson Corporation $MCK - MarketBeat
McKesson Earnings Preview: What to Expect - Yahoo Finance
Private Wealth Partners LLC Has $25.06 Million Holdings in McKesson Corporation $MCK - MarketBeat
EQT raises $15.6B for Asia fund; Apollo to buy minority stake in McKesson unit - S&P Global
Apollo to acquire minority stake in McKesson's medical-surgical solutions business for $1.25bn - pehub.com
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):